Divis Laboratories Ltd
NSE :DIVISLAB BSE :532488 Sector : PharmaceuticalsBuy, Sell or Hold DIVISLAB? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
03 May 3950.95 (-0.35%) | 02 May 3964.65 (-0.94%) | 30 Apr 4002.40 (0.33%) | 29 Apr 3989.25 (-0.67%) | 26 Apr 4016.35 (4.49%) | 25 Apr 3843.80 (0.79%) | 24 Apr 3813.80 (1.20%) | 23 Apr 3768.65 (0.83%) | 22 Apr 3737.50 (1.79%) | 19 Apr 3671.70 (-1.00%) | 18 Apr 3708.90 (-1.47%) | 16 Apr 3764.20 (1.28%) | 15 Apr 3716.55 (-1.67%) | 12 Apr 3779.70 (1.09%) | 10 Apr 3739.10 (-1.73%) | 09 Apr 3804.95 (0.24%) | 08 Apr 3796.00 (1.28%) | 05 Apr 3748.15 (0.37%) | 04 Apr 3734.20 (1.34%) | 03 Apr 3684.90 (1.72%) | 02 Apr 3622.50 (1.53%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Bullish
Medium Term Investors
Very Bullish
Long Term Investors
Neutral
Moving Averages
5 DMA
Bearish
3985.77
10 DMA
Bullish
3876.1
20 DMA
Bullish
3812.24
50 DMA
Bullish
3643.13
100 DMA
Bullish
3700.94
200 DMA
Bullish
3680.39
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On May 03, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 4085.64 | 4038.32 | 3975.98 | - | - |
R2 | 4038.32 | 4003.56 | 3967.63 | 4039.23 | - |
R1 | 3994.64 | 3982.08 | 3959.29 | 3996.46 | 4016.48 |
P | 3947.32 | 3947.32 | 3947.32 | 3948.23 | 3958.24 |
S1 | 3903.64 | 3912.56 | 3942.61 | 3905.46 | 3925.48 |
S2 | 3856.32 | 3891.08 | 3934.27 | 3857.23 | - |
S3 | 3812.64 | 3856.32 | 3925.93 | - | - |
Key Metrics
EPS
51.38
P/E
76.89
P/B
8.33
Dividend Yield
0.76%
Market Cap
1,04,885 Cr.
Face Value
2
Book Value
474.52
ROE
14.89%
EBITDA Growth
583 Cr.
Debt/Equity
0
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Divis Laboratories Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 1821 | 2017 | 1859 | 1995 | 1950 |
PROFIT | 306 | 321 | 356 | 348 | 358 |
EPS | 11.56 | 12.09 | 13.41 | 13.11 | 13.5 |
Divis Laboratories Ltd Quaterly Results
Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | |
INCOME | 1807 | 1974 | 1810 | 1953 | 1902 |
PROFIT | 310 | 319 | 345 | 342 | 358 |
EPS | 11.71 | 12.01 | 12.99 | 12.89 | 13.5 |
Profit & Loss (Figures in Rs. Crores)
Divis Laboratories Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 2725.46 | 3399.24 | 3848.43 | 4180.05 | 4001.6 | 5406.48 | 5690.03 | 7110.63 | 9597.53 | 8089.14 | |
PROFIT | 775.2 | 857.11 | 1128.59 | 1061.58 | 881.41 | 1353.05 | 1335.11 | 1986.75 | 2962.1 | 1824.25 | |
EPS | 27.43 | 30.04 | 42.41 | 39.95 | 33.04 | 50.96 | 51.86 | 74.75 | 111.53 | 68.69 |
Divis Laboratories Ltd Profit & Loss
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | ||
INCOME | 2711.61 | 3357.67 | 3793.98 | 4121.4 | 3947.8 | 5280.46 | 5594.53 | 6961.14 | 9441.07 | 7924.15 | |
PROFIT | 793.59 | 852.61 | 1114.16 | 1054.41 | 872.13 | 1313.87 | 1331.25 | 1957.17 | 2950.19 | 1809.02 | |
EPS | 28.13 | 29.87 | 41.84 | 39.68 | 32.76 | 50.2 | 51.71 | 73.64 | 111.08 | 68.12 |
Balance Sheet (Figures in Rs. Crores)
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | 26.55 | 26.55 |
Reserves Total | 12,714 | 11,675.09 | 9,241.52 | 7,256.83 | 6,904.06 | 5,871.71 | 5,304.3 | 4,240.21 | 3,468.81 | 2,936.8 |
Total Shareholders Funds | 12,767.09 | 11,728.18 | 9,294.61 | 7,309.92 | 6,957.15 | 5,924.8 | 5,357.39 | 4,293.3 | 3,495.36 | 2,963.35 |
Secured Loans | 0 | 0 | 0.35 | 33.63 | 105.6 | 63.11 | 35.74 | 42.47 | 25.07 | 16.87 |
Unsecured Loans | 3.26 | 3.69 | 4.48 | 5.22 | 0 | 0 | 0 | 0 | 1.55 | 1.55 |
Total Debt | 3.26 | 3.69 | 4.83 | 38.85 | 105.6 | 63.11 | 35.74 | 42.47 | 26.62 | 18.42 |
Other Liabilities | 30.62 | 26.71 | 25.25 | 20.52 | 13.17 | 14.95 | 15.3 | 11.57 | 6.99 | 3.18 |
Total Liabilities | 12,800.97 | 11,758.58 | 9,324.69 | 7,369.29 | 7,075.92 | 6,002.86 | 5,408.43 | 4,347.34 | 3,528.97 | 2,984.95 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 6,364.76 | 5,624.27 | 4,691.86 | 3,514.25 | 2,633.93 | 2,373.45 | 1,793.95 | 2,196.08 | 1,953.02 | 1,740.34 |
Less: Accumulated Depreciation | 1,642.16 | 1,299.22 | 987.99 | 732.4 | 546.16 | 377.26 | 234.76 | 757.32 | 644.13 | 518.5 |
Net Block | 4,722.6 | 4,325.05 | 3,703.87 | 2,781.85 | 2,087.77 | 1,996.19 | 1,559.19 | 1,438.76 | 1,308.89 | 1,221.84 |
Capital Work in Progress | 211.88 | 469.93 | 710.62 | 919.69 | 491.91 | 119.76 | 443.57 | 263.91 | 218.18 | 144.48 |
Investments | 77.05 | 72.01 | 0.01 | 971.36 | 1,945.6 | 1,889.29 | 1,630.73 | 802.86 | 733 | 501.88 |
Inventories | 3,000.41 | 2,828.62 | 2,145.23 | 1,863.86 | 1,772.34 | 1,350.67 | 1,319.91 | 1,207.83 | 1,162.64 | 932.42 |
Sundry Debtors | 1,792.53 | 2,423.88 | 1,676.52 | 1,413.35 | 1,163.37 | 1,014.36 | 900.92 | 880.92 | 741.64 | 723.7 |
Cash and Bank Balance | 4,213.09 | 2,818.88 | 2,156.03 | 122.63 | 115.26 | 112.46 | 78.7 | 73.43 | 65.22 | 40.51 |
Loans and Advances | 305.71 | 280.12 | 196.93 | 308.64 | 200.74 | 168.35 | 80.26 | 62.01 | 69.89 | 57.85 |
Total Current Assets | 9,311.74 | 8,351.5 | 6,174.71 | 3,708.48 | 3,251.71 | 2,645.84 | 2,379.79 | 2,224.19 | 2,039.39 | 1,754.48 |
Current Liabilities | 1,093.46 | 1,188.9 | 1,102.83 | 880.06 | 735.85 | 586.67 | 622.43 | 475.33 | 429.81 | 298.96 |
Provisions | 7.13 | 5.83 | 8.49 | 12.39 | 5.3 | 3.64 | 1.28 | 2.17 | 320.14 | 311.58 |
Total Current Liabilities & Provisions | 1,100.59 | 1,194.73 | 1,111.32 | 892.45 | 741.15 | 590.31 | 623.71 | 477.5 | 749.95 | 610.54 |
Net Current Assets | 8,211.15 | 7,156.77 | 5,063.39 | 2,816.03 | 2,510.56 | 2,055.53 | 1,756.08 | 1,746.69 | 1,289.44 | 1,143.94 |
Deferred Tax Assets | 31.25 | 36.04 | 16.27 | 14.57 | 11.99 | 14.29 | 48.9 | 81.18 | 6.67 | 0 |
Deferred Tax Liability | 554.22 | 442.97 | 351.1 | 284.15 | 230.83 | 205.94 | 171.73 | 154.31 | 132.89 | 115 |
Net Deferred Tax | -522.97 | -406.93 | -334.83 | -269.58 | -218.84 | -191.65 | -122.83 | -73.13 | -126.22 | -115 |
Other Assets | 101.26 | 141.75 | 181.63 | 149.94 | 258.92 | 133.74 | 141.69 | 168.24 | 105.67 | 87.81 |
Total Assets | 12,800.97 | 11,758.58 | 9,324.69 | 7,369.29 | 7,075.92 | 6,002.86 | 5,408.43 | 4,347.34 | 3,528.97 | 2,984.96 |
Contingent Liabilities | 89.03 | 89.03 | 7.06 | 7.71 | 360.77 | 350.11 | 273.19 | 77.78 | 83.01 | 80.8 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | 53.09 | 26.55 | 26.55 |
Reserves Total | 12,652.33 | 11,638.26 | 9,218.48 | 7,263.6 | 6,920.22 | 5,906.56 | 5,355.82 | 4,303.95 | 3,535.41 | 3,007.87 |
Total Shareholders Funds | 12,705.42 | 11,691.35 | 9,271.57 | 7,316.69 | 6,973.31 | 5,959.65 | 5,408.91 | 4,357.04 | 3,561.96 | 3,034.42 |
Secured Loans | 0 | 0 | 0.35 | 33.63 | 105.6 | 63.11 | 35.74 | 41.42 | 25.07 | 16.32 |
Unsecured Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.05 | 1.55 | 2.1 |
Total Debt | 0 | 0 | 0.35 | 33.63 | 105.6 | 63.11 | 35.74 | 42.47 | 26.62 | 18.42 |
Other Liabilities | 30.62 | 26.71 | 25.25 | 20.52 | 13.17 | 14.95 | 15.3 | 11.57 | 6.99 | 3.18 |
Total Liabilities | 12,736.04 | 11,718.06 | 9,297.17 | 7,370.84 | 7,092.08 | 6,037.71 | 5,459.95 | 4,411.08 | 3,595.57 | 3,056.02 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 6,357.25 | 5,617.69 | 4,685.46 | 3,508.06 | 2,633.29 | 2,372.92 | 1,793.57 | 2,195.42 | 1,952.4 | 1,739.79 |
Less : Accumulated Depreciation | 1,638.49 | 1,296.72 | 986.45 | 731.8 | 545.85 | 377.04 | 234.62 | 756.78 | 643.67 | 518.19 |
Net Block | 4,718.76 | 4,320.97 | 3,699.01 | 2,776.26 | 2,087.44 | 1,995.88 | 1,558.95 | 1,438.64 | 1,308.73 | 1,221.6 |
Capital Work in Progress | 211.88 | 469.93 | 710.62 | 919.69 | 491.91 | 119.76 | 443.57 | 263.91 | 218.18 | 144.48 |
Investments | 84.41 | 79.37 | 7.37 | 978.72 | 1,952.96 | 1,896.66 | 1,639.09 | 813.04 | 735.82 | 504.69 |
Inventories | 2,780.45 | 2,644.05 | 2,042.7 | 1,744.17 | 1,663.18 | 1,281.39 | 1,255.76 | 1,162.89 | 1,114.9 | 893.27 |
Sundry Debtors | 1,964.3 | 2,569.9 | 1,745.56 | 1,533.21 | 1,282.24 | 1,112.11 | 1,002.89 | 966.12 | 823.03 | 791.64 |
Cash and Bank Balance | 4,187.56 | 2,803.68 | 2,142.01 | 107.36 | 105.2 | 91.48 | 66.47 | 59.38 | 56.66 | 35.77 |
Loans and Advances | 303.14 | 278.33 | 195.04 | 305.08 | 198.53 | 179.64 | 83.31 | 66.86 | 68.38 | 56.86 |
Total Current Assets | 9,235.45 | 8,295.96 | 6,125.31 | 3,689.82 | 3,249.15 | 2,664.62 | 2,408.43 | 2,255.25 | 2,062.97 | 1,777.53 |
Current Liabilities | 1,073.45 | 1,164.25 | 1,086.03 | 866.85 | 725.81 | 576.44 | 618.82 | 469.31 | 426.61 | 294.69 |
Provisions | 4.92 | 4.15 | 2.51 | 2.46 | 1.11 | 0.94 | 1.28 | 4.81 | 320.14 | 311.58 |
Total Current Liabilities & Provisions | 1,078.37 | 1,168.4 | 1,088.54 | 869.31 | 726.92 | 577.38 | 620.1 | 474.12 | 746.75 | 606.27 |
Net Current Assets | 8,157.08 | 7,127.56 | 5,036.77 | 2,820.51 | 2,522.23 | 2,087.24 | 1,788.33 | 1,781.13 | 1,316.22 | 1,171.26 |
Deferred Tax Assets | 15.67 | 21.57 | 13.04 | 10.19 | 9.65 | 13.25 | 41.7 | 74.02 | 0 | 0 |
Deferred Tax Liability | 552.88 | 442.97 | 351.1 | 284.15 | 230.83 | 205.94 | 171.73 | 154.31 | 132.45 | 121.67 |
Net Deferred Tax | -537.21 | -421.4 | -338.06 | -273.96 | -221.18 | -192.69 | -130.03 | -80.29 | -132.45 | -121.67 |
Other Assets | 101.12 | 141.63 | 181.46 | 149.62 | 258.72 | 130.86 | 160.04 | 194.65 | 149.07 | 135.65 |
Total Assets | 12,736.04 | 11,718.06 | 9,297.17 | 7,370.84 | 7,092.08 | 6,037.71 | 5,459.95 | 4,411.08 | 3,595.57 | 3,056.02 |
Contingent Liabilities | 89.03 | 89.03 | 7.06 | 7.71 | 360.77 | 350.11 | 273.19 | 77.78 | 83.01 | 80.8 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 2,368.63 |
Depreciation | 343.18 |
Interest (Net) | -204.26 |
P/L on Sales of Assets | 1.13 |
Prov. and W/O (Net) | 0.33 |
P/L in Forex | 9.7 |
Total Adjustments (PBT and Ext... | 144.94 |
Operating Profit before Workin... | 2,513.57 |
Trade and 0ther Receivables | 650.41 |
Inventories | -171.79 |
Trade Payables | -34.06 |
Total Adjustments (OP before W... | 418.81 |
Cash Generated from/(used in) ... | 2,932.38 |
Direct Taxes Paid | -472.65 |
Total Adjustments(Cash Generat... | -472.65 |
Cash Flow before Extraordinary... | 2,459.73 |
Net Cash from Operating Activi... | 2,459.73 |
Purchased of Fixed Assets | -473.02 |
Sale of Fixed Assets | 0.01 |
Interest Received | 204.59 |
Net Cash used in Investing Act... | -2,707.62 |
Of Financial Liabilities | -0.43 |
Dividend Paid | -796.41 |
Interest Paid | -0.33 |
Net Cash used in Financing Act... | -797.17 |
Net Profit before Tax and Extr... | 2,354.1 |
Depreciation | 342.07 |
Interest (Net) | -204.41 |
P/L on Sales of Assets | 1.13 |
P/L in Forex | -15.51 |
Total Adjustments (PBT and Ext... | 118.14 |
Operating Profit before Workin... | 2,472.24 |
Trade and 0ther Receivables | 638.07 |
Inventories | -136.4 |
Trade Payables | -29.53 |
Total Adjustments (OP before W... | 447.3 |
Cash Generated from/(used in) ... | 2,919.54 |
Direct Taxes Paid | -471.59 |
Total Adjustments(Cash Generat... | -471.59 |
Cash Flow before Extraordinary... | 2,447.95 |
Net Cash from Operating Activi... | 2,447.95 |
Purchased of Fixed Assets | -472.15 |
Sale of Fixed Assets | 0.01 |
Interest Received | 204.59 |
Inter Corporate Deposits | -4,040.38 |
Net Cash used in Investing Act... | -2,706.75 |
Dividend Paid | -796.41 |
Interest Paid | -0.18 |
Net Cash used in Financing Act... | -796.59 |
Company Details
Registered Office |
|
Address | 1-72-23(P)/DIVIS/303 Divi Towe, Cyber Hills Gachibowli |
City | Hyderabad |
State | Telangana |
Pin Code | 500032 |
Tel. No. | 91-40-23786300/23786352/400 |
Fax. No. | 91-40-23786460 |
mail@divislaboratories.com; cs@divislaboratories.c | |
Internet | http://www.divislabs.com |
Registrars |
|
Address | 1-72-23(P)/DIVIS/303 Divi Towe |
City | Hyderabad |
State | Telangana |
Pin Code | 500032 |
Tel. No. | 91-40-23786300/23786352/400 |
Fax. No. | 91-40-23786460 |
mail@divislaboratories.com; cs@divislaboratories.c | |
Internet | http://www.divislabs.com |
Management |
|
Name | Designation |
Murali K Divi | Chairman & Managing Director |
N V Ramana | Executive Director |
Madhusudana Rao Divi | Whole Time Director (Projects) |
Kiran S Divi | Whole Time Director & CEO |
G Suresh Kumar | Independent Director |
Ranga Rao Ravipati | Independent Director |
K V K Seshavataram | Independent Director |
Ramesh B V Nimmagadda | Chairman(Non Exe)&Director(Ind |
Nilima Motaparti | Whole Time Director -Commercia |
S Ganapaty | Independent Director |
Sunaina Singh | Independent Director |
Kosaraju Veerayya Chowdary | Independent Director |
Satish Choudhury | Company Sec. & Compli. Officer |